Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women

AIMS: GSK3640254 is a next‐generation maturation inhibitor likely to be coadministered with combined oral contraceptives in HIV‐positive women. METHODS: This phase I, open‐label, 1‐way study assessed pharmacokinetic and pharmacodynamic interactions of GSK3640254 200 mg and ethinyl oestradiol 0.03 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Pene Dumitrescu, Teodora, Greene, Thomas J., Joshi, Samit R., Xu, Jianfeng, Johnson, Mark, Halliday, Fiona, Butcher, Laurie, Zimmerman, Eric, Webster, Lindsey, Pham, Theresa T., Lataillade, Max, Min, Sherene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291532/
https://www.ncbi.nlm.nih.gov/pubmed/34427938
http://dx.doi.org/10.1111/bcp.15051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291532/
https://www.ncbi.nlm.nih.gov/pubmed/34427938
http://dx.doi.org/10.1111/bcp.15051

Ejemplares similares